Cellular changes in boric acid-treated DU-145 prostate cancer cells

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Epidemiological, animal, and cell culture studies suggest boron acts as a chemopreventative agent against prostate cancer.
• The DU-145 human prostate cancer cell line is a relevant model for studying these effects.

Purpose of the Study:

• To investigate the specific cellular changes induced by boric acid in the DU-145 human prostate cancer cell line.
• To understand the mechanisms underlying boron's potential chemopreventative effects.

Main Methods:

• Prolonged exposure of DU-145 cells to pharmacologically relevant levels of boric acid.
• Morphological analysis, assessment of beta-galactosidase activity, and quantification of cyclins A-E and MAPK proteins.
• Evaluation of cell adhesion, migration, invasion, F-actin content, and lysosomal compartments.

Main Results:

• Boric acid induced morphological changes including increased granularity, vesicle content, cell spreading, and decreased cell volume.
• Increased beta-galactosidase activity indicated a senescent-like cellular phenotype.
• Dose-dependent reduction in cyclins A-E and MAPK proteins, decreased cell adhesion, migration, invasion, and altered F-actin polymerization.
• Media acidosis correlated with accumulation of LAMP-2-negative acidic compartments.

Conclusions:

• Boric acid induces significant morphological and functional alterations in DU-145 prostate cancer cells.
• These changes suggest boric acid may inhibit cancer cell proliferation and reduce metastatic potential.
• Further research is needed to elucidate the precise molecular mechanisms driving these boron-induced cellular responses.